Skip to main content

Identification of connexins in human oral mucosa and therapeutic effect of irsogladine maleate on aphthous stomatitis

Abstract:

We identified connexins 26 and 32 in human oral mucosa. The presence of the connexins indicates the presence of gap junctions in this tissue. However, immunofluorescence study found no significant differences in the expression of the connexins between patients with aphthons stomatitis and controls. Irsogladine maleate, which reinforces gap junctional intercellular communication in vitro, was effective for the treatment of transient and relapsing aphthous stomatitis, as well as symptomatic and drug-induced aphthous stomatitis. It was also useful for prevention of episodes of relapsing aphthous stomatitis, with daily administration preverting recurrence of stomatitis for more than 4 years one patient. These findings suggest that irsogladine maleate accelerates the wound healing process in oral mucosa by reinforcing gap junctional intercellular communication among oral mucosal cells; and that it is useful for the treatment and prevention of aphthous stomatitis.

This is a preview of subscription content, access via your institution.

Author information

Affiliations

Authors

Additional information

(Received Jan. 27, 1998; accepted July 24, 1998)

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Hara, A., Murata, T., Uemura, R. et al. Identification of connexins in human oral mucosa and therapeutic effect of irsogladine maleate on aphthous stomatitis. J Gastroenterol 34, 1–6 (1999). https://doi.org/10.1007/s005350050208

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s005350050208

  • Key words: oral mucosa
  • gap junction
  • connexin
  • aphthous stomatitis
  • irsogladine maleate